Eris Lifesciences Limited — Board Meeting, 30-06-2025: Outcome of Board Meeting

Eris Lifesciences has announced a board meeting on which the following key decisions were taken: Re-appointment of Mr. Amit Indubhushan Bakshi as Managing Director and three Whole Time Directors—Mr. Inderjeet Singh Negi, Mr. Kaushal Kamlesh Shah, and Mr. Krishnakumar Vaidyanathan—for five-year terms starting between October 2025 and April 2026. The company also plans to appoint M/s. Walker Chandiok & Co LLP as its new statutory auditor for five years, replacing Deloitte Haskins & Sells LLP, subject to shareholder approval at the upcoming Annual General Meeting scheduled for July 25, 2025.